Please login to the form below
Istodax
This page shows the latest Istodax news and features for those working in and with pharma, biotech and healthcare.
Novartis gets OK for panobinostat in myeloma
followed three years later by Celgene's rival CTCL therapy Istodax (romidepsin). .
Latest news
-
Celgene's cancer drug promising in small HIV study
Lymphoma therapy Istodax shows potential in treating the virus. A cancer drug sold by Celgene could be used to drive HIV from hidden reservoirs within the body so the virus becomes ... Study leader Ole Schmeltz Søgaard from Aarhus University in Denmark
-
FDA gives early green light to Spectrum’s lymphoma drug
Spectrum's Folotyn anti-folate drug (pralatrexate) was cleared in 2009 for use in patients with relapsed or refractory PTCL while Celgene got the nod for its HDAC inhibitor Istodax (romidepsin) ... Spectrum claims Beleodaq has a broader mechanism than
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Account Supervisor – Leading Healthcare Advertising Agency – New...
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writers > Scientific Directors – Medical Communicatio...
-
Highly Competitive Salary, Bonus &Benefits
- Scientific Director, MRNA/ Covid 19, Medical Communications, UK
-
Six figure salary
- Principal Medical Writer, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Vaccines writer – career opportunity to move into medcomms from ...
-
Highly competitive salary
-
B2B media account director
-
Competitive salary
- Senior Account Exec > CSD – Medical Communications – UK, Lond...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Medical Writer – Creative Healthcare Advertising – New Yo...
-
Highly Competitive Salary, Bonus &Benefits
- First trial of a vaccine against Alzheimer’s launches
- Roche to present new data for its drug Polivy at the American Society of Hematology’s annual meeting
- Gilead’s Trodelvy approved for triple-negative breast cancer in Europe
- Merck enters agreement with Hanmi for investigational NASH drug
- US government to pay $5.3bn for Pfizer‘s Paxlovid
- Novo Nordisk growth takes a hit with China deal
PMHub
Dovetail
We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...
Latest intelligence
- What does the future hold for Light-chain Amyloidosis?
- Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
- Webinar:
- Securing a future for telehealth with immersive market research insights...
- Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
- How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
